- Home
- BMY vs CRWD Comparison
BMY vs CRWD Comparison
Compare BMY & CRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- CRWD
- Stock Information
- Founded
- BMY 1887
- CRWD 2011
- Country
- BMY United States
- CRWD United States
- Employees
- BMY N/A
- CRWD N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- CRWD EDP Services
- Sector
- BMY Health Care
- CRWD Technology
- Exchange
- BMY Nasdaq
- CRWD Nasdaq
- Market Cap
- BMY 99.7B
- CRWD 106.3B
- IPO Year
- BMY N/A
- CRWD 2019
- Fundamental
- Price
- BMY $47.13
- CRWD $411.14
- Analyst Decision
- BMY Hold
- CRWD Buy
- Analyst Count
- BMY 15
- CRWD 45
- Target Price
- BMY $57.64
- CRWD $461.29
- AVG Volume (30 Days)
- BMY 9.7M
- CRWD 3.6M
- Earning Date
- BMY 10-30-2025
- CRWD 08-27-2025
- Dividend Yield
- BMY 5.22%
- CRWD N/A
- EPS Growth
- BMY N/A
- CRWD N/A
- EPS
- BMY 2.49
- CRWD N/A
- Revenue
- BMY $47,704,000,000.00
- CRWD $4,341,102,000.00
- Revenue This Year
- BMY N/A
- CRWD $23.41
- Revenue Next Year
- BMY N/A
- CRWD $21.85
- P/E Ratio
- BMY $19.11
- CRWD N/A
- Revenue Growth
- BMY 2.57
- CRWD 23.46
- 52 Week Low
- BMY $42.96
- CRWD $242.25
- 52 Week High
- BMY $63.33
- CRWD $517.98
- Technical
- Relative Strength Index (RSI)
- BMY 49.09
- CRWD 38.63
- Support Level
- BMY $46.65
- CRWD $404.28
- Resistance Level
- BMY $48.51
- CRWD $448.00
- Average True Range (ATR)
- BMY 0.86
- CRWD 12.08
- MACD
- BMY -0.04
- CRWD 0.74
- Stochastic Oscillator
- BMY 16.89
- CRWD 17.57
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.